Confluence Investment Management LLC Eli Lilly & CO Transaction History

Confluence Investment Management LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Jan 25, 2021	SELL	$130.46 - $172.63 $313,104 - $414,312	-2,400 Closed	0 $0
Q1 2019 Apr 16, 2019	SELL	$111.31 - $131.02 $2,003 - $2,358	-18 Reduced 0.74%	2,400 $311,000
Q4 2018 Jan 04, 2019	SELL	$105.9 - $118.64 $2,647 - $2,966	-25 Reduced 1.02%	2,418 $280,000
Q3 2018 Oct 25, 2018	SELL	$85.86 - $107.31 $515 - $643	-6 Reduced 0.24%	2,443 $262,000
Q2 2018 Jul 12, 2018	BUY	$75.7 - $86.88 $185,389 - $212,769	2,449 New	2,449 $209,000
Q1 2018 Apr 04, 2018	SELL	$74.21 - $87.6 $181,740 - $214,532	-2,449 Closed	0 $0
Q3 2017 Oct 13, 2017	BUY	$77.07 - $85.54 $188,744 - $209,487	2,449	2,449 $209,000

4,010

752M

8.27M

10.5M

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $756B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

Get notified when there are updates to the investment portfolio of Confluence Investment Management LLC, based on Form 13F filings with the SEC.

Stay updated on Confluence Investment Management LLC with notifications on news.